Application of Drug-Coated Balloons in Complex High Risk and Indicated Percutaneous Coronary Interventions.

ABSTRACT: There is a growing trend of patients with significant comorbidities among those referred for percutaneous coronary intervention (PCI). Consequently, the number of patients undergoing complex high risk indicated PCI (CHIP) is rising. CHIP patients frequently present with factors predisposing to extensive drug-eluting stent (DES) implantation, such as bifurcation and/or heavily calcified coronary lesions, which exposes them to the risks associated with an increased stent burden. The drug-coated balloon (DCB) may overcome some of the limitations of DES, either through a hybrid strategy (DCB and DES combined) or as a leave-nothing-behind strategy (DCB-only). As such, there is a growing interest in extending the application of DCB to the CHIP population. The present review provides an outline o

SUBMITTER: Somsen YBO 

PROVIDER: S-EPMC11788978 | biostudies-literature | 2025 Feb

REPOSITORIES: biostudies-literature